✦ LIBER ✦

ONTARGET study of telmisartan, ramipril, or both in high-risk patients

✍ Scribed by C. Venkata S. Ram

Book ID: 107541608
Publisher: Springer
Year: 2008
Tongue: English
Weight: 185 KB
Volume: 10
Category: Article
ISSN: 1522-6417
DOI: 10.1007/s11906-008-0065-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ONTARGET: Use of ramipril, telmisartan,

ONTARGET: Use of ramipril, telmisartan, or both in patients with high cardiovascular risks

✍ HoWon Lee; Amgad N. Makaryus; Samy I. McFarlane 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 163 KB

Telmisartan, ramipril, or both in patien

Telmisartan, ramipril, or both in patients at high risk for vascular events

✍ Donald G. Vidt 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 142 KB

Single and dual blockade of the renin-an

Single and dual blockade of the renin-angiotensin system in high-risk patients without heart failure: Lessons from ONTARGET

✍ Paolo Verdecchia; Fabio Angeli; Giovanni Mazzotta; Chiara Dembech; Gianpaolo Reb 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 163 KB

ONTARGET: Does dual blockade of the reni

ONTARGET: Does dual blockade of the renin-angiotensin system provide more effective cardiovascular and renal protection in patients at high cardiovascular risk?

✍ Jean-Michel Halimi; Albert Mimran 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 200 KB

Study of Off-pump coronary artery bypass

Study of Off-pump coronary artery bypass grafting in high risk patients

✍ S Mehta; U Shah; A Patel 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 17 KB

High dose folinic acid/etoposide/5-fluor

High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer — a phase II study in elderly patients or patients with cardiac risk

✍ H. Wilke; P. Preusser; U. Fink; W. Achterrath; L. Lenaz; M. Stahl; C. Schober; H 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 389 KB

Thirty-four consecutive patients with measurable advanced gastric cancer were treated in a disease oriented Phase II study with high-dose folinic acid (HDFA) 300 mg/m2 10 min. inf., followed immediately by etoposide 120 mg/m2 50 min. inf., followed immediately by 5-fluorouracil (5-FU) 500 mg/m2 10 m